Neville Young

Dr Neville Young joined the Yorkshire & Humber Academic Health Science Network in June 2016. He has a real interest and track record in supporting the delivery of high-quality research and innovation in the UK. Within Yorkshire he is responsible for supporting the adoption of high quality innovation that benefits patients and drives efficiencies in the NHS. Nationally, Neville is currently a board member of the NIHR Imapact Advisory and NIHR reviewer, sits on the NHS AI Lab Advisory group and is currently Vice Chair of the SBRI cancer panel. Neville has previously been Chair of the AHSN Clinical Directors Forum and is involved in the AHSN network strategy development, plays a leading role in developing the networks position on real world evaluation, working closely with NICE, ABHI and the ABPI on this subject. He also supports UK businesses who wish to export and works closely with Department of International Trade (DIT) and the regional Local Enterprise Partnership (LEP) to attract investment into the region from international territories. Dr Young has worked as an academic researcher, a drug trial manager, a consultant, as a director for a health tech start up and is focused on helping to identify and support the “pull" from the healthcare systems for innovative health technologies. He completed his doctorate in Molecular Embryology from Kings College London, before working at the Institute of Cancer Research in London and then the Institute of Molecular Bio-Sciences in Queensland, Australia before returning to the UK and working in research development, Healthtech innovation and the AHSN network.